DAXOR CORP

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.

DXRNasdaqHealthcareMedical Instruments & Supplies
$11.16 +0.80 (+7.77%)

Company Overview

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.

Price Chart

Historical Trend (Absolute Values)
DXR Price
05/1805/2706/03

Financial Metrics

Market Capitalization$61.89M
P/E Ratio6.8049
Earnings Per Share (EPS)$2
Dividend Yield
Beta (Volatility)0.293
Price to Book (P/B)1.2306
52-Week Range$8.29 - $14.76

LAST SCRARED: June 3, 2026

Compare DXR

Analyze valuation multiples and growth parameters side-by-side with other public equities.

Compare Stock Now
VersusHub

© 2026 VersusHub. All rights reserved.